Which Doctors Are Getting Paid By Glaxo, Lilly and Merck?


Published On: December 16th, 2009

pilldollarGlaxoSmithKline has become the latest big pharma company to disclose payments to health-care providers, listing 3,700 U.S. doctors and others who received a total of $14.6 million in speaking and consulting fees during the second quarter.

Glaxo limits payments to an individual physician to $150,000 a year; the average payment in the report was $3,909. Next year it plans to expand what it discloses. Here’s the list of recent payments. Here’s more on the company’s policy and an FT story on the report.

Glaxo joins a parade of drug companies that have started to shed light on their payments to health-care providers, all hoping to show some transparency before Congress makes good on a threat to make some disclosures mandatory. (See p. 1,542 of the Senate health-care bill.)

Others in the parade so far include:

Eli Lilly listed its payments to docs in a “faculty registry” first posted earlier this year. The company limits compensation for education and consulting activity to no more than $75,000 a year.

Merck disclosed payments to U.S. speakers for promotional medical-education activities in the third quarter. Here’s more on Merck’s disclosure plan.

Pfizer will begin disclosing payments to health-care professionals for consulting, speaking engagements and clinical trials exceeding $500 a year and non-monetary items such as meals exceeding $25. That reporting will start in the first quarter of 2010, and will expand in 2011 to “all payments, meals and reimbursable travel expenses, regardless of their individual or aggregate value”

Image: iStockphoto

Read the original: 
Which Doctors Are Getting Paid By Glaxo, Lilly and Merck?



Loading...


Comments are closed.